Jazz Pharmaceuticals plc — Director's Dealing 2018

Dec 15, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2018-12-14

Reporting Person: Hooper Suzanne Sawochka (EVP & General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-14	Ordinary Shares	M	3295	$46.83	Acquired	44518	Direct
2018-12-14	Ordinary Shares	S	3295	$140.21	Disposed	41223	Direct
2018-12-14	Ordinary Shares	S	39	$140.21	Disposed	41184	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-14	Non-Qualified Stock Option (right to buy)	$46.83	M	3295	Disposed	2022-08-08	Ordinary Shares (3295)	Direct

Footnotes

F1: Includes 173 ordinary shares acquired on May 31, 2018 and 72 shares acquired on November 30, 2018 under a Section 423 Employee Stock Purchase Plan.

F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3: This non-qualified stock option is part of an option award granted on August 9, 2012. The ordinary shares subject to the option award vested over 4 years from the vesting commencement date of August 9, 2012, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of August 9, 2016.